We are live on ! Find out more
BCM

Bayesian Capital Management Portfolio holdings

AUM $81.9M
1-Year Est. Return 26.59%
This Fund
S&P 500
This Quarter Est. Return
-15.8%
1 Year Est. Return
+26.59%
3 Year Est. Return
+112.98%
5 Year Est. Return
+129.77%
10 Year Est. Return
+1,146.62%
AUM
$537M
AUM Growth
-$133M
Cap. Flow
-$47.6M
Cap. Flow %
-8.86%
Top 10 Hldgs %
11.25%
Holding
1,208
New
454
Increased
145
Reduced
142
Closed
463

Top Buys

Rank Stock Value
1
TMUS icon
T-Mobile US
TMUS
+$10.5M
2
TFC icon
Truist Financial
TFC
+$8.46M
3
QCOM icon
Qualcomm
QCOM
+$8.04M
4
WBA
Walgreens Boots Alliance
WBA
+$4.59M
5
EOG icon
EOG Resources
EOG
+$4.52M

Sector Composition

Rank Sector Weight
1 Technology 20.77%
2 Healthcare 13.14%
3 Consumer Discretionary 12.35%
4 Industrials 11.65%
5 Financials 10.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FVRR icon
326
Fiverr
FVRR
$398M
$516K 0.1%
14,997
+6,400
+74% +$304K
VRTX icon
327
Vertex Pharmaceuticals
VRTX
$122B
$516K 0.1%
1,831
-7,869
-81% -$2.11M
RUN icon
328
Sunrun
RUN
$2.38B
$513K 0.1%
+21,949
New +$527K
ONB icon
329
Old National Bancorp
ONB
$10.1B
$510K 0.1%
34,500
+6,400
+23% +$98.6K
S icon
330
SentinelOne
S
$6.22B
$510K 0.1%
21,839
-262
-1% -$7.35K
URI icon
331
United Rentals
URI
$70.2B
$505K 0.09%
+2,078
New +$611K
ARRY icon
332
Array Technologies
ARRY
$848M
$504K 0.09%
+45,774
New +$452K
PDCO
333
DELISTED
Patterson Companies, Inc.
PDCO
$504K 0.09%
16,642
+5,900
+55% +$185K
APP icon
334
Applovin
APP
$139B
$503K 0.09%
+14,598
New +$587K
ARKG icon
335
ARK Genomic Revolution ETF
ARKG
$1.54B
$503K 0.09%
+15,978
New +$559K
FFIV icon
336
F5
FFIV
$23B
$500K 0.09%
3,268
-2,000
-38% -$348K
CMI icon
337
Cummins
CMI
$91.3B
$497K 0.09%
+2,567
New +$513K
B
338
Barrick Mining
B
$62.6B
$494K 0.09%
27,900
-48,100
-63% -$1.04M
PATK icon
339
Patrick Industries
PATK
$2.81B
$492K 0.09%
+14,249
New +$564K
BBWI icon
340
Bath & Body Works
BBWI
$4.13B
$490K 0.09%
+18,204
New +$790K
NVT icon
341
nVent Electric
NVT
$24.1B
$486K 0.09%
+15,500
New +$528K
CCXI
342
DELISTED
ChemoCentryx, Inc.
CCXI
$486K 0.09%
+19,600
New +$432K
MRVI icon
343
Maravai LifeSciences
MRVI
$987M
$483K 0.09%
17,000
-15,645
-48% -$496K
ABNB icon
344
Airbnb
ABNB
$87.2B
$481K 0.09%
+5,400
New +$703K
ESTC icon
345
Elastic
ESTC
$6.37B
$481K 0.09%
+7,101
New +$517K
OLED icon
346
Universal Display
OLED
$3.81B
$480K 0.09%
+4,746
New +$610K
CVSA
347
Covista Inc
CVSA
$4.09B
$478K 0.09%
+13,275
New +$418K
LITE icon
348
Lumentum
LITE
$55.4B
$476K 0.09%
+5,996
New +$512K
NKLA
349
DELISTED
Nikola Corporation Common Stock
NKLA
$476K 0.09%
+3,330
New +$681K
FLGT icon
350
Fulgent Genetics
FLGT
$556M
$474K 0.09%
+8,700
New +$478K

Similar funds

Bayesian Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Bayesian Capital Management held 1,208 positions worth $537M, down 20% from $670M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Bayesian Capital Management withdrew a net $47.6M in Q2 2022, closing 463 positions and reducing 142 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $35.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Bayesian Capital Management opened a new position in T-Mobile US worth $10.8M.

  • Bayesian Capital Management's largest Q2 2022 buy was T-Mobile US: 80,110 shares worth $10.8M.
  • Bayesian Capital Management added most to iShares Russell 2000 ETF in Q2 2022, an estimated $4.26M increase.
  • Bayesian Capital Management's biggest Q2 2022 reduction was Verizon, cutting an estimated $4.51M.
  • Bayesian Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q2 2022, selling an estimated $35.6M.
  • Bayesian Capital Management's ten largest holdings make up 11% of its $537M portfolio in Q2 2022.
  • Bayesian Capital Management opened 454 new positions and closed 463 in Q2 2022.
  • Bayesian Capital Management's portfolio value fell 20% quarter-over-quarter to $537M.

Based on Bayesian Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.